How long does a Mounjaro approval last with Kentucky Medicaid?

Initial approvals last 6 months, and renewals are granted in 6-month periods.

What does Kentucky Medicaid require to renew Mounjaro?

Improvement in A1C and At renewal: ICD-10 diagnosis of T2DM (chart notes within past 12 months); A1C value within past 6 months; provider attestation of positive response to therapy (safety and efficacy); no personal/family history of MTC or MEN 2; not used in combination with another GLP-1 or DPP-4 (unless changing therapy); dose does not exceed maximum FDA-approved dose for diabetes.

How current is this information?

This page reflects Kentucky Medicaid's written policy as of July 1, 2026, last verified against the source document on July 7, 2026.

Kentucky Medicaid

Does Kentucky Medicaid cover Mounjaro?

Quick answer · Type 2 Diabetes

Kentucky Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.

Medicaid: Covered (preferred drug). A1C of 6.5% or higher

Last verified July 7, 2026. Policy effective July 1, 2026. Source: kentucky-medicaid-pa-criteria.pdf. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What Kentucky Medicaid requires, by plan type. Open this indication on its own page →

Medicaid

Covered (preferred drug)

What you need to qualify

A1C of 6.5% or higher
Diagnosis documented with a code (E11)
Lab results confirming eligibility

Qualification pathways

You can qualify through any one of these.

Initial approval for Type 2 Diabetes

All of:

ICD-10 diagnosis of T2DM confirmed in chart notes within the past 12 months
A1C lab value >= 6.5% (current within past 6 months, OR historical >= 6.5% PLUS current A1C within past 6 months)
No personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Not used in combination with another GLP-1 receptor agonist OR DPP-4 inhibitor (unless member is changing therapy)
Requested dose does not exceed maximum FDA-approved dose for treatment of diabetes mellitus

Documentation to bring

ICD-10 diagnosis of T2DM in chart notes within the past 12 months
A1C lab value >= 6.5% (current within past 6 months; OR historical >= 6.5% PLUS current A1C within past 6 months)
Attestation of no personal or family history of MTC or MEN 2
Attestation that drug will not be combined with another GLP-1 or DPP-4 inhibitor (unless changing therapy)

Approval and renewal

Initial approval: 6 months
Renewal: every 6 months
To renew, the plan looks for improvement in A1C and At renewal: ICD-10 diagnosis of T2DM (chart notes within past 12 months); A1C value within past 6 months; provider attestation of positive response to therapy (safety and efficacy); no personal/family history of MTC or MEN 2; not used in combination with another GLP-1 or DPP-4 (unless changing therapy); dose does not exceed maximum FDA-approved dose for diabetes.

Not covered when

Drugs used for anorexia, weight loss, or weight gain are excluded from coverage under this benefit (per policy footnote: '*Drugs used for anorexia, weight loss, or weight gain are excluded from coverage.')

Policy note: Mounjaro is a Preferred agent (Preferred with PA). Non-preferred GLP-1s require >= 3-month trial and failure, allergy, contraindication, or intolerance of 2 preferred agents. GLP-1 medications are limited to two brand switches per year. The footnote '*Drugs used for anorexia, weight loss, or weight gain are excluded from coverage' appears in the GLP-1 section and applies to use of these agents for weight loss/anorexia purposes; coverage is limited to the T2DM indication.

Policy effective July 1, 2026 · verified July 7, 2026 · source: kentucky-medicaid-pa-criteria.pdf

Why Mounjaro requests get denied by Kentucky Medicaid

Based on what this policy asks for. Fix these before the first submission.

Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.
Diagnosis code missing or wrong on the request.
No recent A1C result on file.

Frequently asked questions

Does Kentucky Medicaid cover Mounjaro?: Kentucky Medicaid covers Mounjaro for type 2 diabetes with prior authorization on Medicaid.
How long does a Mounjaro approval last with Kentucky Medicaid?: Initial approvals last 6 months, and renewals are granted in 6-month periods.
What does Kentucky Medicaid require to renew Mounjaro?: Improvement in A1C and At renewal: ICD-10 diagnosis of T2DM (chart notes within past 12 months); A1C value within past 6 months; provider attestation of positive response to therapy (safety and efficacy); no personal/family history of MTC or MEN 2; not used in combination with another GLP-1 or DPP-4 (unless changing therapy); dose does not exceed maximum FDA-approved dose for diabetes.
How current is this information?: This page reflects Kentucky Medicaid's written policy as of July 1, 2026, last verified against the source document on July 7, 2026.

Other medications under Kentucky Medicaid

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes Kentucky Medicaid's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.